Ranibizumab Solution For Injection 10 mg /ml

About Ranibizumab Solution For Injection 10 mg /ml

Ranibizumab Solution for Injection 10 mg/ml is a recombinant humanized monoclonal antibody fragment used in the treatment of various retinal and macular disorders. It works by inhibiting vascular endothelial growth factor (VEGF), thereby reducing abnormal blood vessel growth and leakage in the eye, helping to preserve and improve vision.

• Neovascular (Wet) Age-Related Macular Degeneration (AMD)

• Diabetic Macular Edema (DME)

• Macular Edema following Retinal Vein Occlusion (RVO)

• Myopic Choroidal Neovascularization (mCNV)

• Diabetic Retinopathy

• Clinically proven anti-VEGF therapy

• Helps prevent vision loss and improves visual acuity

• High purity, sterile formulation

• Suitable for ophthalmic specialists and hospital use

• To be administered only by a qualified ophthalmologist

• Intravitreal injection as per prescribed treatment protocol

• Store at 2C to 8C

• Do not freeze

• Protect from light

• Keep out of reach of children

• For prescription use only

• Not to be self-administered

• Use under strict aseptic conditions